[Federal Register: February 23, 2006 (Volume 71, Number 36)]
[Notices]               
[Page 9358]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23fe06-66]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Peripheral and Central Nervous System Drugs Advisory Committee; 
Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Peripheral and Central Nervous System 
Drugs Advisory Committee. This meeting was announced in the Federal 
Register of January 27, 2006 (71 FR 4593). The amendment is being made 
to reflect a change in Date and Time and Procedure portions of the 
document. An additional day is being added to this meeting and the 
length of time allotted for the open public hearing portion is being 
extended. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Sohail Mosaddegh, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: 
sohail.mosaddegh@fda.hhs.gov, or the FDA Advisory Committee Information 

Line, 1-800-741-8138 (301-443-0572 in the Washington DC area), code 
3014512543. Please call the Information Line for up-to-date information 
on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of January 27, 2006, 
FDA announced that a meeting of the Peripheral and Central Nervous 
System Drugs Advisory Committee would be held on March 7, 2006, from 8 
a.m. to 5 p.m., and the open public hearing portion scheduled between 
approximately 1 p.m. and 2 p.m. On page 4593, in the third column, the 
Date and Time portion of the document is amended to read as follows:
    Date and Time: The meeting will be held on March 7 and 8, 2006, 
from 8 a.m. to 5 p.m.
    On page 4594, in the first column, in the Procedure portion of the 
document, the third sentence is amended to read as follows:
    Procedure: Oral presentations from the public will be scheduled 
between approximately 1 p.m. and 5 p.m. on March 7, 2006.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: February 15, 2006.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E6-2541 Filed 2-22-06; 8:45 am]

BILLING CODE 4160-01-S